Search Results

Displaying Results 126-150 of 602 "'CR'"

Dec 18, 2025, 09:03 ET Crunch Fitness Top Franchisee Levels Up Dallas-Fort Worth With Four New Gym Openings

delivering a high-quality fitness experience," said Tony Scrimale, CEO of CR Fitness Holdings. "Our 3.0 model brings elevated amenities, advanced equipment, and an energetic environment that supports the communities we serve."CR Fitness Holdings is on track to operate 100 locations nationwide by 2026.

More news about: CR Fitness Holdings, LLC.


Dec 17, 2025, 09:03 ET Top Crunch Fitness Franchisee Doubles Down in Dallas-Fort Worth, On Track for 17 Clubs in Texas

experience in the fitness industry. CR Fitness Holdings LLC currently has 88 locations across Florida, Georgia, North Carolina, Texas, and Tennessee, with plans to expand into Arizona. The franchisee has plans to reach 100 clubs by 2026.About CR Fitness Holdings, LLCCR Fitness Holdings, LLC. is the

More news about: CR Fitness Holdings, LLC.


Dec 16, 2025, 05:59 ET Breakthrough Progress: METiS TechBio Publishes Consecutive Research Findings in Nature Communications and the Journal for ImmunoTherapy of Cancer

Complete Tumor Regression: In advanced HPV18⁺MC38 tumor models, MTS-107 combined with PD-1 blockade achieved 100% complete response (CR).Spleen-Targeted LNP Delivery: Enhances antigen presentation and T cell activation.Dual-Subtype

More news about: METiS TechBio


Dec 15, 2025, 04:58 ET Innoviti Receives ASK Private Hurun India Unicorn & Future Unicorn Award

payments-centric SaaS software is used by enterprise brands and their SME channel partners across online and offline payment channels, processing over Rs. 80,000 Cr. annually from across 2000 cities and over 20,000 merchants. The company processes more than 50% of all purchases happening in enterprise retailers in

More news about: Innoviti Technologies Pvt. Ltd.


Dec 12, 2025, 11:19 ET Hedgeye Asset Management Launches the Hedgeye 130/30 Equity ETF (HELS) Managed by R. Patrick Kent

extension, and thematic global equity portfolios. His career includes senior roles at Wellington Management, BNY Mellon/Newton Investment Management, and CR Intrinsic. Throughout his career, Kent has integrated Hedgeye's macro and stock research into his investment process, applying a disciplined approach

More news about: Hedgeye Asset Management


Dec 12, 2025, 09:03 ET Top Crunch Fitness Franchisee Brings First-Ever HVLP Reformer Pilates Studio to McKinney, Texas

with plans to expand into Arizona.About CR Fitness Holdings, LLCCR Fitness Holdings, LLC is the leading franchisee of Crunch Fitness, and led by a management team with over 150 years of combined experience in the fitness industry. CR Fitness is on track to operate 100 locations nationwide

More news about: CR Fitness Holdings, LLC.


Dec 12, 2025, 08:45 ET Actinium Pharmaceuticals Presents New Preclinical Data Demonstrating Potent Anti-Tumor Activity of ATNM-400 Across Multiple Breast Cancer Subtypes Including Hormone Receptor-Positive, Triple-Negative, and Tamoxifen- and HER2 Therapy-Resistant Breast Cancer Models at SABCS 2025

relapsed and refractory acute myeloid leukemia (r/r AML) patients in combination with the chemotherapy CLAG-M including high rates of Complete Remissions (CR) and measurable residual disease (MRD) negativity leading to improved survival outcomes and is being advanced to a pivotal Phase 2/3 trial. In addition,

More news about: Actinium Pharmaceuticals, Inc.


Dec 12, 2025, 00:38 ET TELUS Announces Upsizing and Results of its Cash Tender Offers for Seven Series of Debt Securities

-4.75% Notes,Series CR dueJanuary, 2045C$400,000,000

More news about: TELUS Corporation


Dec 12, 2025, 00:38 ET TELUS Announces Upsizing and Results of its Cash Tender Offers for Seven Series of Debt Securities

-4.75% Notes,Series CR dueJanuary, 2045C$400,000,000

More news about: TELUS Corporation


Dec 11, 2025, 12:30 ET TalkShopLive Appoints Former TikTok Ecommerce Leader Sandie Hawkins as CEO Amid Strategic Expansion

https://www.dropbox.com/scl/fi/cr6zlcynnk2d7yfn5146x/Sandie-Hawkins.jpg?rlkey=iqm15cvn0qz9qkxfp947hy5pr&st=8sjec5jp&dl=0LOS ANGELES, Dec.

More news about: talkshoplive


Dec 11, 2025, 10:01 ET SK Chemicals effectue la première intégration verticale du recyclage en Corée grâce à un approvisionnement interne en matières premières

recyclage chimique à Shantou en Chine, créant ainsi un centre mondial pour le recyclage circulaire avec la production commerciale de r-BHET et de CR-PET. En Corée, l'entreprise a construit le centre d'innovation du recyclage (Recycle Innovation Center - RIC) dans son usine d'Ulsan, reliant les installations

More news about: SK Chemicals


Dec 11, 2025, 09:25 ET SK Chemicals realisiert durch die hausinterne Beschaffung von Rohstoffen die erste vertikale Integration im Recyclingbereich in Korea

chemisches Recycling in Shantou, China, und schuf damit einen globalen Hub für zirkuläres Recycling mit der kommerziellen Produktion von r-BHET und CR-PET. In Korea hat das Unternehmen in seinem Werk in Ulsan das Recycle Innovation Center (RIC) errichtet, das Pilotanlagen zur Depolymerisation mit der Copolyester-Produktion

More news about: SK Chemicals


Dec 11, 2025, 08:30 ET Market For Geologic Hydrogen & Carbon Capture Is Burgeoning, With Revenues Projected to Hit Over $50 Billion

a mineralized zone exceeding 700 metres strike length, individual lenses up to 45 metres long by 10 metres wide, and microprobe grades up to 60.45% Cr₂O₃."Natural accumulations of geologic hydrogen are being found all over the world, but in most cases they are small and not economical, although

More news about: FN Media Group, LLC


Dec 11, 2025, 07:30 ET TuHURA Biosciences Provides Corporate Update Following Recent Financing

while menin inhibitors have become standard of care in NPM1 mutated AML, there still exists a significant unmet medical need, citing the relatively low CR rate and short duration of response as the two obstacles to improving clinical benefit in these patients."Dr. Bianco continued, "The VISTA gene

More news about: TuHURA Biosciences, Inc.


Dec 11, 2025, 07:22 ET Citius TransNet Investment Trust Files Draft Offer Document with SEBI for Rs 1,340 Cr InvIT

content:https://www.prnewswire.com/in/news-releases/citius-transnet-investment-trust-files-draft-offer-document-with-sebi-for-rs-1-340-cr-invit-302639103.html

More news about: Citius TransNet Investment Trust


Dec 10, 2025, 18:34 ET SK Chemicals logra la primera integración vertical de Corea en reciclaje

producción basada en el reciclaje químico en Shantou (China), creando un centro global para el reciclaje circular con la producción comercial de r-BHET y CR-PET. En Corea, la empresa ha construido el Centro de Innovación en Reciclaje (RIC) en su planta de Ulsan, conectando las instalaciones piloto de despolimerización

More news about: SK Chemicals


Dec 10, 2025, 08:30 ET IceCure's ProSense® Cryoablation Featured in 4 Independent Breast Cancer Studies Presented at Radiological Society of America 2025 Annual Meeting

mm), followed by Cryoablation-only (61.7%, mean reduction of 8.2 mm), and HT-only (42.1%, mean reduction of 7.4 mm). Tumors with complete remission (CR, RECIST 1.1) were similar between the Cryoablation-with-HT and Cryoablation-only groups (74.4% and 78.3%, respectively), followed by the HT-only (36.1%).

More news about: IceCure Medical


Dec 10, 2025, 08:00 ET SK Chemicals achieves Korea's first vertical integration in recycling through in-house feedstock sourcing

recycling-based production subsidiary in Shantou, China, in 2023, creating a global hub for circular recycling with the commercial production of r-BHET and CR-PET. In Korea, the company has built the Recycle Innovation Center (RIC) at its Ulsan plant, linking depolymerization pilot facilities with copolyester

More news about: SK Chemicals


Dec 10, 2025, 02:00 ET SK Chemicals achieves Korea's first vertical integration in recycling through in-house feedstock sourcing

recycling-based production subsidiary in Shantou, China, in 2023, creating a global hub for circular recycling with the commercial production of r-BHET and CR-PET. In Korea, the company has built the Recycle Innovation Center (RIC) at its Ulsan plant, linking depolymerization pilot facilities with copolyester

More news about: SK Chemicals


Dec 09, 2025, 08:00 ET Curis Provides Updated Data from its Frontline AML Triplet Study

to the combination with venetoclax and azacitidine (ema-ven-aza) in AML patients being treated with ven-aza in the frontline setting who have achieved CR but remain MRD-positive. Emavusertib has received Orphan Drug Designation from the U.S. Food and Drug Administration for the treatment of PCNSL, AML

More news about: Curis, Inc.


Dec 09, 2025, 07:44 ET Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI® plus DARZALEX FASPRO® as a potential standard of care as early as second line for patients with relapsed/refractory multiple myeloma

combination across varied patient measures.1 TECVAYLI® plus DARZALEX FASPRO® showed higher rates of complete response (≥CR) (81.8% vs. 32.1%; odds ratio [OR], 9.56; 95% CI, 6.47-14.14), overall response (89.0% vs. 75.3%; OR, 2.65; 95% CI, 1.68-4.18) and MRD-negativity (58.4%

More news about: Johnson & Johnson


Dec 09, 2025, 05:00 ET Dizal Showcases its Strong Hematology Pipeline with New Data from Golidocitinib and Birelentinib at ASH 2025

maintenance after CHOP, showed an ORR of 94.1% and a CR rate of 64.7%. By the data cutoff date, 85% of patients remained on treatment.Golidocitinib 150mg daily with CHOP, followed by 150mg maintenance after CHOP, showed an ORR of 88.9% and a CR rate of 61.1% R/R

More news about: Dizal Pharmaceutical


Dec 09, 2025, 02:47 ET Innoviti Appoints Sandeep Mina As Chief Business Officer - Retail

payments-centric SaaS software is used by enterprise brands and their SME channel partners across online and offline payment channels, processing over Rs. 80,000 Cr. annually from across 2000 cities and over 20,000 merchants. The company processes more than 50% of all purchases happening in enterprise retailers in

More news about: Innoviti Technologies Pvt. Ltd.


Dec 08, 2025, 12:00 ET Sumitomo Pharma America Presents New Investigational Data on Enzomenib and Nuvisertib at the 2025 American Society of Hematology Annual Meeting and Exposition

received a prior menin inhibitor. In the NPM1m dose optimization population (n=25, pts who received ≥ 200 mg BID), ORR is 52% and CR+CR is 44% with a duration of CR+CRh of 5.7 months. The mOS was 8.5 months."Despite improved understanding of the genetic factors of certain high-risk subtypes

More news about: Sumitomo Pharma America


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.